Sartorius receives award for outstanding performance in its production chain
Company's manufacturing building for laboratory instruments in Göttingen wins the Global Excellence in Operations Award.
Manufacturing operations at Sartorius has received a prize for outstanding performance in its value creation chain. At the competition for the Factory of the Year 2018 Award hosted annually by the German production trade journal Produktion and the global management consulting firm A.T. Kearney, the Sartorius manufacturing building for laboratory instruments in Göttingen won the GEO Award – Global Excellence in Operations. This prize will be conferred to Sartorius in March 2019 at the GEO Conference in Ludwigsburg, Germany.
Each of the competing production chains was assessed by performance indicators that were benchmarked, such as customer satisfaction, quality or innovation. These, in turn, involved several assessment criteria, including cost management, resource efficiency and customer focus.
“Our thanks go out to the entire team that faced up to the challenges posed by the competition and to all staff members who have shaped the transformative activities over the past years and helped to implement the changes and improvements. With our drive to provide customers with the best possible service, I see the Global Excellence in Operation Award as confirmation that we are on the right track, and as an incentive to go forward,” said Matthias Wessel, Head of Operations of the Sartorius Lab Products & Services Division.
Around 450 employees manufacture laboratory instruments, such as balances, ultrapure water systems and moisture analysers in the building covering some 25,000 m2. As high-precision weighing instruments are also calibrated inside, the building is protected from temperature fluctuations and by a vibration-decoupled foundation.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance